rheumatoid arthritis

EMA panel recommends nod for Sanofi, Regeneron's arthritis drug
Yahoo/Reuters
Sat, 04/22/17 - 01:14 pm
Europe
EMA
Sanofi
Regeneron
rheumatoid arthritis
Kevzara
Sarilumab
Lilly and Incyte's Loss Is AbbVie and Regeneron's Gain
Motley Fool
Mon, 04/17/17 - 12:09 pm
Eli Lilly
Inctye
AbbVie
Regeneron
rheumatoid arthritis
FDA
baricitinib
Humira
The FDA shot down a new rheumatoid arthritis drug — and the companies that make the drug are tumbling
Yahoo/Business Insider
Mon, 04/17/17 - 11:32 am
FDA
rheumatoid arthritis
Eli Lilly
Incyte
baricitinib
Eli Lilly and Incyte say FDA failed to approve their rheumatoid arthritis drug
Marketwatch
Fri, 04/14/17 - 10:48 am
Eli Lilly
Incyte
FDA
rheumatoid arthritis
baricitinib
$5B in Humira sales at stake with Amgen EU approval
BioPharma Dive
Sat, 03/25/17 - 12:18 pm
Humira
Amgen
Europe
rheumatoid arthritis
Amgevita
biosimiliars
Pfizer Announces Approval By The China Food And Drug Administration Of XELJANZ®, The First Oral JAK Inhibitor For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis
Yahoo
Thu, 03/16/17 - 09:45 am
Pfizer
China
Xeljanz
rheumatoid arthritis
Pfizer Reports Top-Line Results for Rheumatoid Arthritis Treatment Study
Yahoo/GuruFocus
Mon, 02/27/17 - 10:11 pm
Pfizer
rheumatoid arthritis
Xeljanz
Amgen Signs Value-Based Deal for Enbrel (AMGN)
Investopedia
Thu, 02/23/17 - 09:39 pm
Amgen
Enbrel
rheumatoid arthritis
Pfizer + relationship expert = RA connection?
BioPharma Dive
Fri, 02/17/17 - 09:55 am
Pfizer
rheumatoid arthritis
Xeljanz
Pfizer says rheumatoid arthritis drug is comparable to Humira as combination treatment but not alone
Marketwatch
Thu, 02/16/17 - 03:13 pm
Pfizer
Xeljanz
AbbVie
Humira
rheumatoid arthritis
Three kinds of drugs, like those that treat RA and diabetes, drive increase in spending
Medical Marketing and Media
Wed, 02/8/17 - 09:24 pm
drug spending
diabetes
rheumatoid arthritis
oncology
Pfizer's New Biosimilar Is Off and Running
Motley Fool
Sat, 02/4/17 - 10:00 am
Pfizer
biosimilars
Remicade
JNJ
Inflectra
rheumatoid arthritis
Novartis says court battle will delay its Enbrel copy until 2018 at least
Yahoo/Reuters
Wed, 01/25/17 - 09:58 am
Novartis
Enbrel
patents
Erelzi
Amgen
biosimilars
rheumatoid arthritis
Barictinib FDA Delay Only A 'Short-Term Setback' For Eli Lilly, Says Credit Suisse
Yahoo/Benzinga
Tue, 01/17/17 - 10:18 pm
Eli Lilly
baricitinib
rheumatoid arthritis
FDA delays decision on Lilly and Incyte's arthritis drug
BioPharma Dive
Tue, 01/17/17 - 11:04 am
FDA
Eli Lilly
Incyte
rheumatoid arthritis
baricitinib
Migraine drugs may repeat rheumatoid arthritis success
Yahoo/Reuters
Sat, 12/24/16 - 12:19 pm
migraines
rheumatoid arthritis
biologics
Pfizer’s Xeljanz Expected to See Strong Growth Trends in 2016
Market Realist
Thu, 11/17/16 - 04:52 pm
Pfizer
Xeljanz
rheumatoid arthritis
J&J, GSK stumble coming out of the gate with mixed PhIII rheumatoid arthritis data for sirukumab
Endpoints
Sun, 11/13/16 - 12:00 pm
JNJ
GSK
rheumatoid arthritis
sirukumab
AbbVie
Humira
Boehringer flags PhIII success for another Humira knockoff, setting up a crowded field of cheaper rivals — eventually
Endpoints
Wed, 10/26/16 - 09:16 pm
Boehringer Ingelheim
Humira
BI 695501
AbbVie
rheumatoid arthritis
UCB’s Cimzia AutoClicks pen hits the U.K. market
Mass Device
Wed, 10/26/16 - 08:54 am
UCB Pharma
Cimzia
UK
devices
rheumatoid arthritis
Cimzia AutoClick

Pages